HOME > February 14, 2023
Daily News
February 14, 2023
- Sawai President Sounds Negative about M&As, but Agrees Generic Industry Needs Consolidation
February 14, 2023
- Japan Should Create Drug Discovery Command Tower: Chugai Honorary Chair
February 14, 2023
- Asahi Kasei Pharma Poised for a String of Approvals and Launch in 2023
February 14, 2023
- Sawai President Declares Plan to Raise Shipment Prices in FY2023
February 14, 2023
- Trade Group Calls for Predictability around SaMD Reimbursement: LDP Gathering
February 14, 2023
- J-TEC’s Cell Sheet for Vitiligo Now in Line for Approval in Japan
February 14, 2023
- Zeria to Take over Japan Marketing Authorization for Dafclir from Astellas
February 14, 2023
- AbbVie Rolls Out Skyrizi Auto-Doser in Japan
February 14, 2023
- Adcetris Filed for CTCL Indication in Japan: Takeda
February 14, 2023
- BMS Mulls CAR-T Manufacturing in Japan, Definitive Plans Expected by Year-End
February 14, 2023
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
